TMEM119 Antibody, anti-human, REAfinity™
Synonyms: Transmembrane protein 119
RECOMBINANT
Clone:
REA1508 | A16075D
Type of antibody:
Recombinant antibodies, Primary antibodies
Isotype:
recombinant human IgG1
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for TMEM119 Antibody, anti-human, REAfinity™

Flow cytometry applications
APC
PE
Vio B515
Vio Bright V423
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-139-838, 130-139-814
Description:
Latex beads were coated with recombinant human TMEM119 protein and then stained with Anti-TMEM119 antibodies or with the corresponding REA control (S) antibodies (left image). Flow cytometry was performed with the MACSQuant® Analyzer.

Application imageView details view details

Application imageView details view details
Specifications for TMEM119 Antibody, anti-human, REAfinity™
Overview

Clone REA1508 recognizes the TMEM119 (transmebrane protein 119), which is a type I transmembrane protein expressed by microglia in the central nervous system.TMEM119 can be downregulated during neuroinflammation or injury, e.g. traumatic brain injury, Alzheimer´s, multiple sclerosis. Additional information: Clone REA1508 displays negligible binding to Fc receptors.

Alternative names

Transmembrane protein 119

Detailed product information

Technical specifications

Clone
REA1508
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (S), human IgG1
Host
cell line
Type of antibody
Recombinant antibodies, Primary antibodies
Species reactivity
human
Antigen
TMEM119
Distribution of antigen
microglia

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for TMEM119 Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for TMEM119 Antibody, anti-human, REAfinity™
Publications
  1. Bohnert, S. et al. (2020) TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination. Int J Legal Med 134 (6): 2167-2176
  2. Lier, J. et al. (2021) Beyond Activation: Characterizing Microglial Functional Phenotypes. Cells 10 (9): 2236

You have previously chosen International as your location.
What do you want to do?